title: Second-line dovitinib in metastatic endometrial cancer.
authors.affiliation: Department of Oncology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Block
authors.affiliation: Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA. Electronic address: dowdy.sean@mayo.edu.
authors.forename: Sean C
authors.initials: SC
authors.lastname: Dowdy
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D001562:Benzimidazoles / Q000008:administration & dosage*; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015363:Quinolones / Q000008:administration & dosage*; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000235:genetics*
chemical_list: D001562:Benzimidazoles; D015363:Quinolones; D051497:Receptor, Fibroblast Growth Factor, Type 2